ZOGENIX RAISES $60M

Zogenix, a privately held pharmaceutical company, raised $60 million in financing Monday to help it bring a device to market that migraine sufferers can use to self-inject medicine without a needle. he company paid $4 million for the subcutaneous injection device, known as Intraject, from Aradigm, a Hayward, California-based biotech -- a deal that was also announced Monday.

Red Herring (http://www.redherring.com/Article.aspx?a=18215&hed=Zogenix%2BRaises%2B%2460M)